Sentences with phrase «with the biotech company sanaria»

What's more, this is only the first of 10 similar deals with biotech companies, according to the outlet.

Cuomo called the state's $ 200 million deal with the biotech company Athenex «a game - changer for Dunkirk.»

Robl and Stice, in collaboration with the biotech company Genzyme of Cambridge, Massachusetts, have already created embryos that contain the human gene for albumin protein, which helps restore the blood's osmotic pressure after blood loss.

My second placement was with a biotech company called Chromos Molecular Systems, where I was able to put into practice the principals of technology transfer that I had learned at UBC.

That will require cooperation with biotech companies.

Want to be in a new position with a biotech company next year at this time?

In order to separate the 200 - some compounds in breast milk so they could be analyzed individually, Lebrilla worked with a biotech company to develop a microchip that acts like a filter for the machine, allowing different compounds through at different speeds.

Another indication of how relevant the biotech industry has become here is the recent joint creation by UBC and BCIT of a bachelor of science degree in biotechnology, which includes co-op work terms with biotech companies.

University of Tübingen researchers in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria ® PfSPZ - CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine.

For Pancer, the award enabled his return to academic research in the United States after holding a position with a biotech company in Israel.

For example, scaling up manufacturing, regulatory issues, and partnerships with biotech companies.

In 2001 Scheller began a new career with the biotech company Genentech as Senior Vice President for Research, where he enjoyed the freedom to continue basic research and publishing new findings in cell biology, including proteins called Rab GTPases, which regulate the transport of structures within cells.

In the past, when we've talked to various pharmaceutical companies about one program or another in our lab, they often want to wait until it's been developed into a preliminary screen, and would rather work with biotech companies for collaborations — they've often been the intermediate window before a pharmaceutical company would step in.

We recently spoke to Dr. Ron Gonzalez, co-founder and CEO of Instant Chemistry, about the latest developments with the biotech company — which has included a few setbacks — and what exciting plans it has for the future.

venture capital fund formed a joint venture with a biotech company hoping to quickly advance three of the biotech's drug candidates through Phase I. And AstraZeneca and Merck are each contributing an experimental cancer drug candidate for a novel early - stage clinical program.

Otherwise, I'm interviewing with a biotech company for a great sales position and I'm going through the process with Abbott, Merck and AstraZeneca.

Amy is looking for a procurement position with a biotech company in the Boston Area.

I am seeking a Specialty Sales position with a biotech company that appreciates representatives with years of experience.

I also have over 5 years» experience as a Field Application Specialist with a biotech company which is a similar position as a Pre-sales and Medical Device Expert at a biotechnology company.

Not exact matches

One biotech firm, Ossianix, is already hard at work developing a VNAR - based drug - delivery system, in collaboration with the global pharmaceutical company Lundbeck, which focuses on drugs for brain disorders.

Gilead Sciences — Gilead fell 19 cents a share shy of estimates with adjusted quarterly profit of $ 1.48 per share, and the biotech company's revenue also fell short of Street forecasts.

Big biotech and pharma companies are absolutely dependent on being able to successfully innovate by partnering with and acquiring disruptive startups because of the nature of the patent cliff in pharmaceuticals.

And within a span of six weeks this fall, Hillary Clinton caused a drop in biotech stocks with a tweet calling for greater regulation of drug prices, then single - handedly tanked stocks of private - corrections companies when she tweeted about prison reform.

Andrew Olsen writes: I was struck by the contrast between how established biotech and pharmaceutical companies have dealt with this problem vs. what you described in your 6 step process.

Of the companies that did go public this year, the healthcare sector has seen the most activity with 96 IPOs, largely due to a biotech boom.

Instead, he did it the same way a fast - growth software or biotech company develops products — with a small team, angel funding, freewheeling management, a willingness to take big risks, and a belief that serious profit lay on the far side.

The genetics company received a payment of $ 10 million (with «as much as $ 50 million» in additional payments down the line) from the biotech firm in exchange for access to its library of genetic data, Forbes reports.

Next, Morihara was recruited to run two private biotech companies in the Bay Area that were struggling with management problems.

Yesterday, the company announced that it is teaming up with the biotech firm Genetech to try and identify new treatments for Parkinson's disease.

Google - backed biotech company Calico has also forged a partnership with a Chicago - based biopharmaceutical firm to develop age - defying drugs.

Roughly one year after tendering a founding investment in biotech company Calico, Google is breaking ground on a brand new Bay Area research facility with a lofty life - prolonging aim.

The Fidelity Growth Company grew 36.8 percent last year, with its stakes in tech and biotech helping boost results.

Tax breaks and other incentives have created a thriving biotech industry in Belgium, with many companies spun off from university projects now listed on its stock exchange.

The company just announced a lucrative deal with the biotech firm Genetech, and says many similar deals are in the works.

With a biotech startup, it may seem the potential is all in the science, but investor Amy Schulman, a venture capital partner at Polaris Partners, which led SQZ's $ 5 million funding round, says the main reason she decided to put money in SQZ is because of Sharei, even though he's young and had never started a company before.

«We've responded to the competitive environment by focusing on industries that are currently out of favor with the public - equity market, like biotech, medical devices, and early - stage information - technology companies,» says Patrick Boroian, a general partner at Sprout, which is the New York City - based venture - capital affiliate of financial - services giant Donaldson, Lufkin & Jenrette.

CNBC's Meg Tirrell speaks with Verily Chief Medical Officer Dr. Jessica Mega about the role Alphabet plays in the biotech company and what it could mean for the future of medicine.

Sticking with the corporate space, the board of biotech firm Shire announced that it had received a revised acquisition proposal of # 46 billion ($ 64 billion) from Takeda Pharmaceutical Company.

Immuno - oncolocy has been the focus of Big Pharma and biotechs alike, with companies such as Merck (mrk), Bristol - Myers Squibb (bmy), Pfizer (pfe), Roche / Genentech, Juno (juno), Kite Pharma (kite), Novartis (nvs), and countless others pouring massive investments into the space (the Loncar ETF contains almost all of these companies).

The premiums that pharma companies pay for biotechs with mid-to-late stage experimental drugs has risen to a point that has some analysts crying «bubble.»

Kite Pharma, Juno Therapeutics, and Bluebird Bio are among a growing group of biotech companies working with CAR - T.

DuPont Pioneer has been collaborating on research and intellectual property with Caribou Biosciences, the biotech company cofounded by Jennifer Doudna, one of the discoverers of CRISPR, for sometime now.

The Kamens claim the main thing that distinguishes their foundation from other brain tumor foundations is their focus on pediatric brain cancer specifically, as well as their close ties with pharmaceutical and biotech companies working in the fields of immunotherapy and target gene therapy.

Minoryx is a clinical stage biotech company leading the development of new therapies for X-linked Adrenoleukodystrophy (X-ALD) and other inborn errors of metabolism, a group of rare diseases of genetic origin with a high unmet medical need.

Fortune Brainstorm Health, in association with IBM Watson Health, gathers not only C - suite leaders of top companies, hospitals, insurers, and cutting - edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care.

BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies.

We are fortunate to partner closely with scientists, entrepreneurs and executives who are building transformative biotech and tech companies.

Regina gained profound insights into the fast - growing biotech sector as a university lecturer and post-doctoral researcher at the University of Vienna and the MRC Cambridge, where she collaborated with emerging UK biotech companies.

In his Transformational Technology Alert research advisory, Patrick Cox leverages his over 30 years of experience as a consultant, writer, and researcher in the tech / biotech space to bring to you the small - cap tech and medical companies with the potential to transform our lives.

«We are pleased to share this vision with the unique blend of crossover funds, pharmaceutical companies, and venture capital investors participating in our Series B, and look forward to advancing our position as the leading biotech with a dual focus on synthetic lethality and immuno - oncology.»